Condition: Kidney Neoplasms · Sponsor: RenJi Hospital
Zero ischemia laparoscopic radio frequency ablation assisted tumor enucleation has been proved to enable tumor excision with relatively better renal function preservation comparing with conventional laparoscopic partial nephrectomy for T1a renal cell carcinoma (RCC) in a randomized clinical trial in single center. The investigators want to explore this technique to robotic surgery and add suture-less technique to T1 RCC patients in randomized clinical trial.
This description comes directly from the study's public registry record.
Jiwei Huang, PhD. · 02168383204 · huangjiwei@renji.com
Yiran Huang, MD. · +8613501835219 · huangyrrenji@163.com
Always discuss trial participation with your own doctor first.
| Ethics Committee of Shanghai Renji Hospital | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06715878